| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2010 | Octogenarians with advanced non-small cell lung cancer: Treatment modalities, survival, and prognostic factors | Chen K.-Y.; Chen J.-H.; Shih J.-Y.; Yang C.-H.; CHONG-JEN YU ; Yang P.-C. | Journal of Thoracic Oncology | 13 | 11 | |
| 2013 | Outcome correlation of smear-positivity for acid-fast bacilli at the fifth month of treatment in non-multidrug-resistant TB | Chien J.-Y.; Chen Y.-T.; Shu C.-C.; Lee J.-J.; Wang J.-Y.; CHONG-JEN YU ; Yang P.-C. | Chest | 8 | 8 | |
| 2008 | Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment | Lin Z.-Z.; Hsu C.; Chang Y.-C.; CHONG-JEN YU ; Hsu C.-H.; Lin C.-C.; Cheng A.-L.; Yang P.-C.; Yang C.-H. | Lung Cancer | 4 | 1 | |
| 2004 | Outcome of coal worker's pneumoconiosis with acute respiratory failure | Shen H.-N.; Jerng J.-S.; CHONG-JEN YU ; Yang P.-C. | Chest | 7 | 7 | |
| 2018 | Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study | Lin C.-C.; Shih J.-Y.; CHONG-JEN YU ; Ho C.-C.; Liao W.-Y.; Lee J.-H.; Tsai T.-H.; Su K.-Y.; Hsieh M.-S.; Chang Y.-L.; Bai Y.-Y.; Huang D.D.-R.; Thress K.S.; Yang J.C.-H. | The Lancet Respiratory Medicine | 51 | 50 | |
| 2017 | Outcomes of cancer therapy administered to treatment-na?ve lung cancer patients in the intensive care unit | Chen Y.-F.; Lin J.-W.; Ho C.-C.; Yang C.-Y.; Chang C.-H.; Huang T.-M.; Chen C.-Y.; Chen K.-Y.; Shih J.-Y.; CHONG-JEN YU | Journal of Cancer | 8 | 7 | |
| 2018 | Outcomes of research biopsies in clinical trials of EGFR mutation-positive non-small cell lung cancer patients pretreated with EGFR-tyrosine kinase inhibitors | Liao B.-C.; Bai Y.-Y.; Lee J.-H.; Lin C.-C.; Lin S.-Y.; Lee Y.-F.; Ho C.-C.; Shih J.-Y.; Chang Y.-C.; CHONG-JEN YU ; Chih-Hsin Yang J.; Yang P.-C. | Journal of the Formosan Medical Association | 8 | 7 | |
| 1996 | Overexpression of MUC5 genes is associated with early post-operative metastasis in non-small-cell lung cancer | CHONG-JEN YU ; Yang P.-C.; Shun C.-T.; Lee Y.-C.; Kuo S.-H.; Luh K.-T. | International Journal of Cancer | 46 | ||
| 2004 | Overexpression of Placenta Growth Factor Contributes to the Pathogenesis of Pulmonary Emphysema | Tsao P.-N.; Su Y.-N.; Li H.; Huang P.-H.; Chien C.-T.; Lai Y.-L.; Lee C.-N.; Chen C.-A.; Cheng W.-F.; Wei S.-C.; CHONG-JEN YU ; Hsieh F.-J.; Hsu S.-M. | American Journal of Respiratory and Critical Care Medicine | 73 | 65 | |
| 2002 | Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a University Hospital, Taiwan | Hsueh P.-R.; Teng L.-J.; Chen C.-Y.; Chen W.-H.; CHONG-JEN YU ; Ho S.-W.; Luh K.-T. | Emerging Infectious Diseases | 206 | ||
| 2006 | Pandrug-resistant Pseudomonas aeruginosa among hospitalised patients: Clinical features, risk-factors and outcomes | Wang C.Y.; Jerng J.S.; Cheng K.Y.; Lee L.N.; CHONG-JEN YU ; Hsueh P.R.; Yang P.C. | Clinical Microbiology and Infection | 83 | ||
| 2006 | Pasteurization is effective against multidrug-resistant bacteria | Wang C.-Y.; Wu H.-D.; Lee L.-N.; Chang H.-T.; Hsu Y.-L.; CHONG-JEN YU ; Yang P.-C.; Hsueh P.-R. | American Journal of Infection Control | 8 | ||
| 2003 | Patient mortality of active pulmonary tuberculosis requiring mechanical ventilation | Lee P.L.; Jerng J.S.; Chang Y.L.; Chen C.F.; Hsueh P.R.; CHONG-JEN YU ; Yang P.C.; Luh K.T. | European Respiratory Journal | 61 | 55 | |
| 2008 | A patient with bronchiectasis presented with progressive dyspnoea and an unresolved right lower lung infiltrate | Lin P.-Y.; CHONG-JEN YU ; Yao M.; Ku S.-C.; Lee L.-N.; Yang P.-C. | Thorax | 0 | 0 | |
| 2010 | Pemetrexed for heavily pretreated patients with advanced non-small cell lung cancer | Lee J.-H.; CHONG-JEN YU ; Chen K.-Y.; Shih J.-Y.; Lin Y.-L.; Yang C.-H. | Journal of the Formosan Medical Association | 6 | 4 | |
| 2012 | Percutaneous computed tomography-guided coaxial core biopsy for small pulmonary lesions with ground-glass attenuation | Lu C.-H.; Hsiao C.-H.; Chang Y.-C.; Lee J.-M.; Shih J.-Y.; Wu L.-A.; CHONG-JEN YU ; Liu H.-M.; Shih T.T.-F.; Yang P.-C. | Journal of Thoracic Oncology | 38 | 40 | |
| 2015 | Performance assessment of the BluePoint MycoID plus kit for identification of Mycobacterium tuberculosis, including rifampin- and isoniazid-resistant isolates, and nontuberculous mycobacteria | Chien J.-Y.; Chang T.-C.; Chiu W.-Y.; CHONG-JEN YU ; Hsueh P.-R. | PLoS ONE | 10 | 9 | |
| 2007 | Performance assessment of the Capilia TB assay and the BD ProbeTec ET system for rapid culture confirmation of Mycobacterium tuberculosis | Wang J.-Y.; Lee L.-N.; Lai H.-C.; Hsu H.-L.; Jan I.-S.; CHONG-JEN YU ; Hsueh P.-R.; Yang P.-C. | Diagnostic Microbiology and Infectious Disease | 35 | 34 | |
| 2012 | Performance assessment of the DR. TBDR/NTM IVD kit for direct detection of Mycobacterium tuberculosis isolates, including rifampin-resistant isolates, and nontuberculous mycobacteria | Lee M.-R.; Cheng A.; Huang Y.-T.; Liu C.-Y.; Chung K.-P.; Wang H.-C.; Liang S.-K.; Liao C.-H.; CHONG-JEN YU ; Hsueh P.-R. | Journal of Clinical Microbiology | 13 | 14 | |
| 2007 | A phase II study of oral vinorelbine in combination with cisplatin conducted in Taiwan in patients with unresectable localized or metastatic non-small cell lung carcinoma | Chen Y.-M.; CHONG-JEN YU ; Yang C.-H.; Perng R.-P.; Tsai C.-M.; Shih J.-F.; Cheng A.-L.; Lefresne F.; Barbier M.; Pouget J.-C.; Yang P.-C. | Lung Cancer | 14 |
